Knock down of BMSC-derived Wnt3a or its antagonist analogs attenuate colorectal carcinogenesis induced by chronic Fusobacterium nucleatum infection

Rong Lin,Chaoqun Han,Zhen Ding,Huiying Shi,Ruohang He,Jun Liu,Wei Qian,Qin Zhang,Xiaochao Fu,Xiaohua Deng,Shunchang Zhou,Xiaohua Hou
DOI: https://doi.org/10.1016/j.canlet.2020.08.032
IF: 9.756
2020-12-01
Cancer Letters
Abstract:<p>By establishing the <em>Fusobacterium nucleatum</em> (<em>F. nucleatum</em>) infected-bone mesenchymal stem cells (BMSCs) transplantation model in APC<sup>Min/+</sup> mice, we investigated the role of BMSCs in the development of intestinal tumors induced by <em>F. nucleatum</em>. Apc<sup>Min/+</sup>+<em>F. nucleatum</em> + BMSCs mice showed increased susceptibility to intestinal tumors and accelerated tumor growth. BMSCs could also enhance tumor-initiating capability, invasive traits after <em>F. nucleatum</em> infection in vitro, and tumorigenicity in a nude murine model. Mechanistically, BMSCs were recruited to the submucosa, migrated to the mucosal layer, and might activate the canonical Wnt/β-catenin/TGIF axis signaling. Further mechanistic results illustrated increased production of the Wnt3a protein was found in Apc<sup>Min/+</sup>+<em>F. nucleatum</em> + BMSCs mice, and BMSCs were likely the major source of Wnt3a. Intriguingly, a deletion of Wnt3a via BMSC interference or antagonist analogs led to a significantly attenuated capacity of Apc<sup>Min/+</sup>+<em>F. nucleatum</em> mice to generate intestinal tumors. The findings suggest that BMSCs have the potential to migrate and accelerate <em>F. nucleatum</em><strong>-</strong>induced colorectal tumorigenesis by modulating Wnt3a secretion; knockdown of BMSC-derived Wnt3a or antagonist analogs could attenuate carcinogenesis. Thus, Wnt3a might be a potential pharmaceutical target for the prevention and treatment of <em>F. nucleatum</em>-related colorectal cancer.</p>
oncology
What problem does this paper attempt to address?